Peptides for microbe-induced cancers: latest therapeutic strategies and their advanced technologies

Ziqi Lin1,2, Yehuda G Assaraf3, Hang Fai Kwok4,5,6

  • 1Cancer Centre, Faculty of Health Sciences, University of Macau, Avenida da Universidade, Taipa, Macau SAR.

PubMed

Insights

Peptide therapies show promise for treating cancers caused by microbes like Helicobacter pylori and viruses such as HPV, HBV, and HCV. This review explores advancements in peptide design and delivery for microbe- and virus-induced cancers.

Area of Science:

  • Oncology
  • Microbiology
  • Virology
  • Therapeutics

Background:

  • Cancer is a major global health issue linked to various factors, including microbial and viral infections.
  • Microorganisms like Helicobacter pylori (H. pylori) and viruses such as human papillomavirus (HPV), hepatitis B virus (HBV), and hepatitis C virus (HCV) are implicated in human malignancies.
  • Peptide-based therapies are emerging as a promising treatment strategy for these specific cancer types.

Purpose of the Study:

  • To provide an overview of cancers induced by microbes and viruses.
  • To elucidate the molecular mechanisms underlying these neoplasms.
  • To review current and developing peptide-based therapies for microbe- and virus-induced cancers.

Main Methods:

  • Literature review of studies on microbe- and virus-induced cancers.
  • Analysis of molecular mechanisms involved in cancer development.
  • Examination of advancements in peptide-based therapy design, screening, and delivery.

Main Results:

  • Identified key microorganisms and viruses associated with cancer development.
  • Discussed molecular pathways linking infections to oncogenesis.
  • Highlighted progress in developing tumor-targeting peptides and microbial/viral peptide-based vaccines.
  • Detailed technological advancements in peptide-based anticancer agent development.

Conclusions:

  • Peptide-based therapies represent a significant area of research and development for treating microbe- and virus-induced cancers.
  • Technological innovations are enhancing the efficacy and delivery of peptide therapeutics.
  • Future prospects for peptide-based treatments in oncology are promising.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
350
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K